Paclitaxel effects on axonal localization and vesicular trafficking of Na(V)1.8

Patients treated with paclitaxel (PTX) or other antineoplastic agents can experience chemotherapy-induced peripheral neuropathy (CIPN), a debilitating side effect characterized by numbness and pain. PTX interferes with microtubule-based transport, which inhibits tumor growth via cell cycle arrest but can also affect other cellular functions including trafficking of ion channels critical to transduction of stimuli by sensory neurons of the dorsal root ganglia (DRG). We examined the effects of PTX on voltage-gated sodium channel Na(V)1.8, which is preferentially expressed in DRG neurons, using a microfluidic chamber culture system and chemigenetic labeling to observe anterograde channel transport to the endings of DRG axons in real time. PTX treatment increased the numbers of Na(V)1.8-containing vesicles traversing the axons. Vesicles in PTX-treated cells exhibited greater average velocity, along with shorter and less frequent pauses along their trajectories. These events were paralleled by greater surface accumulation of Na(V)1.8 channels at the distal ends of DRG axons. These results were consistent with observations that Na(V)1.8 is trafficked in the same vesicles containing Na(V)1.7 channels, which are also involved in pain syndromes in humans and are similarly affected by PTX treatment. However, unlike Na(v)1.7, we did not detect increased Na(V)1.8 current density measured at the neuronal soma, suggesting a differential effect of PTX on trafficking of Na(V)1.8 in soma versus axonal compartments. Therapeutic targeting of axonal vesicular traffic would affect both Na(v)1.7 and Na(v)1.8 channels and increase the possibilities of alleviating pain associated with CIPN.